Nutra Pharma Corporation

Nutra Pharma Corp. (Nutra Pharma) is a biopharmaceutical company engaged in the acquisition, licensing and marketing of pharmaceutical products and technologies for neurological disorders, cancer, autoimmune and infectious diseases. It develops proprietary therapeutic protein products through ReceptoPharm and sells its diagnostic kits through its medical devices subsidiary, Designer Diagnostics. The company is headquartered in Florida, the US. In October 2009, the company launched a prescription analgesic, Nyloxin Rx, for the treatment of severe (Stage 3) chronic pain.The company reported revenues of (U.S. Dollars) USD 0.00 million during the fiscal year ended December 2008, whereas the company's revenue was USD 0.00 during the fiscal year ended 2007. The operating loss of the company was USD 4.16 million during the fiscal year 2008, as compared to an operating loss of USD 0.17 million during 2007. The net loss of the company was USD 4.16 million during the fiscal year 2008, as compared to a net loss of USD 0.17 million during 2007.<

Street: 
791 Park of Commerce Blvd
City: 
Boca Raton
Postcode: 
33487
Federal State : 
United States
WebSite: 
http://www.nutrapharma.com
Fax: 
1-866-7443655

Company Index Score

Current Index Score Historical Index Score
  • Nutra Pharma Corporation currently scores 50 % in the index.
  • Nutra Pharma Corporation is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Nutra Pharma Corporation is currently ranked 1 out of 4535 companies. This is in the top 0.022 % percent of Pharmaceutical companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets